Teva-Fulvestrant Injection 50 mg (Fulvestrant SOLUTION) 50 MG

Teva-Fulvestrant Injection 50 mg is a prescription medication used for hormone receptor-positive breast cancer treatment. This intramuscular solution is manufactured by Teva Canada Limited and is available in 2x5ml packs.

Strength

50 MG

Pack Size

2X5ML

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fulvestrant is a type of hormone therapy used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by blocking the effects of estrogen in the body, which can help slow or stop the growth of certain types of breast cancer cells. This medication is typically used in cases where the cancer has spread to other parts of the body or has returned after initial treatment.

Side Effects

Common effects of Fulvestrant may include injection site reactions, such as pain, swelling, or redness. Some individuals may also experience hot flashes, nausea, or headache. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

Fulvestrant should be used with caution in individuals with a history of liver or kidney problems. It is important to inform your healthcare provider about any other medications you are taking, as well as any allergies or medical conditions you have. This medication should be administered by a healthcare professional to ensure proper dosage and minimize the risk of side effects.

Avoid Interactions

Fulvestrant may interact with other medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Alcohol consumption should be avoided while using this medication, as it may increase the risk of side effects.

Frequently Asked Questions

Fulvestrant is used in the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Fulvestrant is administered as an intramuscular injection, typically by a healthcare professional.

Common side effects may include injection site reactions, hot flashes, nausea, and headache.

Fulvestrant may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Fulvestrant should be used with caution in individuals with liver or kidney problems, and it is important to consult a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.